Carlsmed Inc (CARL)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Carlsmed Inc Stock (CARL) Company Profile

Carlsmed Inc

Healthcare (1111)

858-295-9290

1800 ASTON AVENUE, CARLSBAD

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CARL's Discussions on Twitter

Compare CARL vs VEEV, TEM, BTSG, HQY, DOCS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CARL Carlsmed Inc	10.95	286.14M	0	0	0	0.00
VEEV Veeva Systems Inc	174.11	28.27B	3.08B	860.33M	1.35B	5.1463
TEM Tempus Ai Inc	51.95	9.03B	803.32M	-709.10M	-212.68M	-7.8003
BTSG Brightspring Health Services Inc	38.86	6.82B	11.99B	24.18M	234.31M	0.2956
HQY Healthequity Inc	73.88	6.25B	1.15B	96.70M	-161.99M	1.09
DOCS Doximity Inc	25.02	4.56B	550.17M	201.35M	232.07M	1.00

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-18	Eingeleitet	BTIG Research	Buy
2025-08-18	Eingeleitet	BofA Securities	Buy
2025-08-18	Eingeleitet	Goldman	Buy
2025-08-18	Eingeleitet	Piper Sandler	Overweight
2025-08-18	Eingeleitet	Truist	Buy

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Es liegen keine Finanzdaten für Carlsmed Inc (CARL) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Carlsmed Inc-Aktie (CARL) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Sidow Kevin	Director	Jul 24 '25	Buy	15.00	13,333	199,995	59,566
Mittendorff Robert II	Director	Jul 24 '25	Buy	15.00	1,333,333	19,999,995	5,013,839
ROOT JONATHAN D	Director	Jul 24 '25	Buy	15.00	466,666	6,999,990	483,999
YOUNG PHILIP M	Director	Jul 24 '25	Buy	15.00	59,999	899,985	53,333

Carlsmed Inc (CARL)

Carlsmed Inc Stock (CARL) Company Profile

Compare CARL vs VEEV, TEM, BTSG, HQY, DOCS

Carlsmed Inc Stock (CARL) Upgrades & Downgrades

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to “Hold” - Defense World

Financial Review: Carlsmed (CARL) versus Its Rivals - Defense World

Critical Comparison: Carlsmed (NASDAQ:CARL) vs. TransEnterix (OTCMKTS:TRXDW) - Defense World

Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - The Manila Times

Carlsmed completes first surgery using aprevo bilateral posterior system By Investing.com - Investing.com Nigeria

Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure - Orthopedics This Week

Carlsmed completes first surgery using aprevo bilateral posterior system - Investing.com

Both private equity firms who control a good portion of Carlsmed, Inc. (NASDAQ:CARL) along with institutions must be dismayed after last week's 11% decrease - simplywall.st

TD Waterhouse Canada Inc. Takes $2.03 Million Position in Carlsmed, Inc. $CARL - MarketBeat

Teacher Retirement System of Texas Purchases Shares of 175,000 Carlsmed, Inc. $CARL - MarketBeat

Financial Comparison: Carlsmed (NASDAQ:CARL) & ReShape Lifesciences (OTCMKTS:RSLSD) - Defense World

Bullish Carlsmed Insiders Loaded Up On US$8.10m Of Stock - Yahoo Finance

Analyzing Carlsmed (NASDAQ:CARL) and Perspective Therapeutics (NASDAQ:CATX) - Defense World

Carlsmed (NASDAQ:CARL) Downgraded to Sell Rating by Wall Street Zen - MarketBeat

BTIG Reiterates Buy Rating on CARL, Maintains Price Target | CAR - GuruFocus

AI medtech firm Carlsmed prices $100.5M IPO - MSN

California-based Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer

Carlsmed reports 61% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria

Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 - Ortho Spine News

Carlsmed reports 61% revenue growth in Q4 2025 - Investing.com

More surgeons turn to AI-enabled spine surgery tech as Carlsmed grows - Stock Titan

Carlsmed, Inc.'s Lock-Up Period Set To End on January 19th (NASDAQ:CARL) - MarketBeat

Carlsmed, Inc.’s Lock-Up Period Set To End on January 19th (NASDAQ:CARL) - Defense World

Top Carlsmed (CARL) Competitors 2026 - MarketBeat

Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal - Ortho Spine News

Carlsmed’s personalized implants reduce spine surgery reoperations By Investing.com - Investing.com Nigeria

Carlsmed’s personalized implants reduce spine surgery reoperations - Investing.com

What is the current Price Target and Forecast for Carlsmed, Inc. (CARL) - Zacks Investment Research

Carlsmed Debuts AI-based Custom Implants for Cervical Spine Surgery - San Diego Business Journal

Critical Comparison: Longevity Health (NASDAQ:XAGE) vs. Carlsmed (NASDAQ:CARL) - Defense World

Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference - The Manila Times

Inside the J.P. Morgan healthcare event Carlsmed is joining in 2026 - Stock Titan

BTIG Reiterates Carlsmed (CARL) Buy Recommendation - Nasdaq

Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise By Investing.com - Investing.com South Africa

Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise - Investing.com Nigeria

CARLSMED, INC. (CARL) Competitors - Meyka

CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery - Yahoo Finance

Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - Ortho Spine News

Carlsmed launches personalized cervical fusion implant system By Investing.com - Investing.com Nigeria

Carlsmed Launches Aprevo Platform for Cervical Fusion Surgeries - marketscreener.com

Carlsmed launches personalized cervical fusion implant system - Investing.com

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Umsatz

Nettogewinn

Free Cashflow

ENV

Carlsmed Inc-Aktie (CARL) Insiderhandel

Ähnlich wie CARL